Get the Stockscreener App
4.13
3.50%
-0.15
Pre-market:
4.13
Achieve Life Sciences Inc stock is traded at $4.13, with a volume of 397.03K.
It is down -3.50% in the last 24 hours and down -27.03% over the past month.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.
See More
Previous Close:
$4.28
Open:
$4.29
24h Volume:
397.03K
Relative Volume:
0.60
Market Cap:
$219.86M
Revenue:
-
Net Income/Loss:
$-32.94M
P/E Ratio:
-3.7207
EPS:
-1.11
Net Cash Flow:
$-24.95M
1W Performance:
+4.56%
1M Performance:
-27.03%
6M Performance:
+69.26%
1Y Performance:
+25.53%
1-Day Range:
$4.00
$4.33
1-Week Range:
$3.975
$4.47
52-Week Range:
$1.84
$6.025
Achieve Life Sciences Inc Stock (ACHV) Company Profile
Name
Achieve Life Sciences Inc
Sector
Industry
Phone
425-686-1500
Address
22722 29TH DR. SE, SEATTLE, BC
Compare ACHV vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ACHV
Achieve Life Sciences Inc
|
4.13 | 227.84M | 0 | -32.94M | -24.95M | -1.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.02 | 117.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
783.65 | 82.35B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
833.54 | 51.64B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
308.48 | 42.58B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.42 | 38.87B | 4.98B | 69.60M | 525.67M | 0.5198 |
Achieve Life Sciences Inc Stock (ACHV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-25-25 | Initiated | Citizens JMP | Mkt Outperform |
| Aug-21-25 | Initiated | H.C. Wainwright | Buy |
| Nov-14-24 | Initiated | Rodman & Renshaw | Buy |
| Sep-27-24 | Initiated | Raymond James | Strong Buy |
| May-10-23 | Reiterated | Maxim Group | Buy |
| Jun-23-21 | Initiated | Oppenheimer | Outperform |
View All
Achieve Life Sciences Inc Stock (ACHV) Latest News
Alert wrongly tagged to Achieve Life Sciences withdrawn - marketscreener.com
IPO Launch: What are Achieve Life Sciences Incs recent SEC filings showingQuarterly Profit Report & Accurate Entry and Exit Point Alerts - baoquankhu1.vn
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Analysts Offer Insights on Healthcare Companies: Achieve Life Sciences (ACHV) and Roivant Sciences (ROIV) - The Globe and Mail
Chipmakers Recap: What’s the profit margin of Achieve Life Sciences IncJuly 2025 Final Week & Real-Time Stock Movement Alerts - baoquankhu1.vn
Achieve Life Sciences (NASDAQ:ACHV) Stock Price Crosses Above 200-Day Moving AverageHere's Why - MarketBeat
Achieve Life Sciences: A Binary Bet With Cytisinicline And A Potential 2026 Launch - Seeking Alpha
Franklin Resources Inc's Strategic Acquisition of Achieve Life S - GuruFocus
Achieve Life Sciences: Could Be The Best 'Tobacco' Stock For 2026Strong Buy - Seeking Alpha
Achieve Life Sciences, Inc. (ACHV): A Bull Case Theory - Finviz
Achieve Life Sciences Announced Granting of New Hire Inducement Awards - The Manila Times
Five new hires at Achieve Life Sciences get 115,000 stock options - Stock Titan
Retail Investors Who Have a Significant Stake Must Be Disappointed Along With Institutions After Achieve Life Sciences, Inc.'s (NASDAQ:ACHV) Market Cap Dropped by US$56m - 富途牛牛
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
What is HC Wainwright's Estimate for ACHV FY2026 Earnings? - MarketBeat
FY2030 Earnings Forecast for ACHV Issued By HC Wainwright - Defense World
What is HC Wainwright's Forecast for ACHV FY2030 Earnings? - MarketBeat
Achieve Life Sciences may offer up to $300 million in securities - marketscreener.com
Achieve Life Sciences May Offer Up To $300 Million In Securities - TradingView
Achieve Life Sciences (ACHV) Announces $300M Securities Shelf Registration - GuruFocus
Achieve Life Sciences Files $300 Million Mixed Shelf - marketscreener.com
Portfolio Update: What are Achieve Life Sciences Incs recent SEC filings showingTrade Risk Assessment & Stepwise Swing Trade Plans - baoquankhu1.vn
Fed Watch: Will Achieve Life Sciences Inc benefit from sector rotationJuly 2025 Review & Stepwise Trade Signal Guides - baoquankhu1.vn
Achieve Life Sciences (NASDAQ:ACHV) Stock Passes Above Two Hundred Day Moving AverageHere's What Happened - MarketBeat
Aug PostEarnings: Is Achieve Life Sciences Inc stock trending bullishPortfolio Return Summary & AI Forecasted Entry/Exit Points - baoquankhu1.vn
Quarterly Earnings: Is Achieve Life Sciences Inc forming a breakout patternShort Setup & Free Daily Entry Point Trade Alerts - baoquankhu1.vn
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Is Expected To Breakeven In The Near Future - Yahoo Finance
Whats the fair value of Achieve Life Sciences Inc stockAnalyst Downgrade & Low Risk Investment Opportunities - baoquankhu1.vn
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Given Consensus Recommendation of “Moderate Buy” by Analysts - Defense World
Achieve Life Sciences’ smoking treatment likely to be approved by FDA, says Hunterbrook - MSN
Achieve Life Sciences appoints Mark Rubinstein as permanent CMO By Investing.com - Investing.com Nigeria
Achieve Life Sciences Promotes Mark Rubinstein As Chief Medical Officer - Nasdaq
Achieve Life Sciences (ACHV) Appoints New Chief Medical Officer - GuruFocus
Achieve Life Sciences appoints Mark Rubinstein as permanent CMO - Investing.com
Achieve Life Sciences Confirms Promotion of Dr. Mark Rubinstein to Chief Medical Officer - The Manila Times
Achieve Life Sciences Confirms Mark Rubinstein as Chief Medical Officer - Quiver Quantitative
Achieve Life Sciences, Inc. Confirms Promotion of Dr. Mark Rubinstein to Chief Medical Officer - marketscreener.com
Can Achieve Life Sciences Inc. stock continue upward trendPortfolio Gains Report & AI Enhanced Trading Alerts - Улправда
Why Achieve Life Sciences Inc. stock is recommended by analystsJuly 2025 Market Mood & Weekly Top Stock Performers List - Улправда
Will Achieve Life Sciences Inc. stock benefit from automation2025 Bull vs Bear & Proven Capital Preservation Methods - Улправда
Can Achieve Life Sciences Inc. stock resist sector downturns2025 Trading Volume Trends & Long-Term Capital Growth Strategies - Улправда
Is Achieve Life Sciences Inc. stock undervalued vs historical averages2025 Bull vs Bear & Expert Curated Trade Setups - ulpravda.ru
How supply chain issues affect Achieve Life Sciences Inc. stockGlobal Markets & Momentum Based Trading Ideas - ulpravda.ru
Will Achieve Life Sciences Inc. stock outperform value stocks2025 Geopolitical Influence & High Win Rate Trade Tips - Улправда
Will Achieve Life Sciences Inc. stock deliver strong dividend growth2025 Sector Review & Smart Swing Trading Alerts - Улправда
Achieve Life Sciences, Inc.Common Shares (NQ: ACHV - FinancialContent
Achieve Life Sciences gets new interim chief medical officer - MSN
11 creative campaigns to know about today - Ad Age
Will Achieve Life Sciences Inc. (SP4P) stock rise with strong economyStock Price Divergence & Free Grow Wealth With Picks - Улправда
What analysts say about Achieve Life Sciences Inc stockLow Risk Investment Ideas & Rapid Portfolio Investment - earlytimes.in
Achieve Life Sciences Inc Stock (ACHV) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.24%
0.19%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):